FAQs with Key Opinion Leaders
Join experts as they discuss key developments, targeted therapies and the role of immunotherapy.
Episodes 1-8 of 8
- FAQs with Key Opinion Leaders
Targeted Therapy for Head & Neck Cancer
Tanguy Seiwert, MD
- FAQs with Key Opinion Leaders
Management of Recurrent Squamous Cell Carcinoma of the Head & Neck
- FAQs with Key Opinion Leaders
Management of Head & Neck Cancer
- FAQs with Key Opinion Leaders
Novel Therapies for Head & Neck Cancer
- FAQs with Key Opinion Leaders
Current Recommendations: HPV Tumors in Head & Neck Cancers
Tanguy Seiwert, MD
- FAQs with Key Opinion Leaders
Recent Breakthroughs in Head and Neck Cancer
- Immuno-Oncology (IO) Updates
Role of Immunotherapy in Head & Neck Cancer
Athanassios Argiris, MD, PhD, FACP
- FAQs with Key Opinion Leaders
Key Developments within Head & Neck Cancer
Athanassios Argiris, MD, PhD, FACP